I. Building on Validated Frameworks

Our proposed pipeline synthesizes two monumental achievements in recent computational biology:

  1. D-CLEF (Kuo et al., 2025): A decentralized, privacy-preserving predictive modeling framework that operates without a single-point-of-control central server.
  2. FedECA (Owkin / du Terrail et al., 2025): A federated extension of the Inverse Probability of Treatment Weighting (IPTW) method for estimating treatment effects on distributed time-to-event outcomes.

II. The Engineering Breakthrough: The Proposed Synthesis Sequence

The legacy system assumes you can have privacy (via standard Federated Learning), or you can have causality (via centralized IPTW pooling), but you cannot have both. Building upon Owkin’s foundational FedECA framework, RZST proposes an architectural sequence designed to shatter this bottleneck for neurodegenerative diseases.

01

Localized Propensity Scoring

In our simulation, an algorithm inside the secure hospital node analyzes the raw patient data to calculate the propensity score—the probability that a specific patient received the experimental drug based on their baseline severity.

02

Injecting the Local Equalizer (IPTW)

Still entirely behind the simulated firewall, the system applies the IPTW equations established by du Terrail et al. It mathematically weights the data, synthesizing a “Pseudo-Population” where treatment bias is theoretically flattened.

03

Secure Transmission via D-CLEF

Leveraging the decentralized, blockchain-backed architecture proposed by Kuo et al., the local node packages its learned causal insights into mathematical weight updates. It securely transmits only the loss gradients and weight deltas, completely stripped of Protected Health Information.

04

The Global Synthesis (Federated Averaging)

The network utilizes Federated Averaging to aggregate the data across all nodes:

θglobal(t+1) = ∑k=1K (nk / N) · θk(t+1)

  • θglobal — The central brain (The proposed FedECA Virtual Control Arm)
  • θk — The isolated local model at simulated hospital node k
  • nk / N — The weighting factor ensuring proportional representation across the network

We propose that θglobal becomes a statistically pure, bias-corrected Virtual Control Arm derived entirely from decentralized data.

III. The Bioethical Leverage

In a standard clinical trial, T=1 represents the patient receiving the drug, and T=0 represents the human forced to receive the placebo. In our theoretical architecture, we redefine T=0.

We propose that T=0 now equals θglobal. By synthesizing these frameworks, we offer a blueprint to make the physical administration of sugar pills to terminal ALS patients scientifically and ethically obsolete.

This is not a claim of clinical efficacy. It is a provable mathematical theory and a software architecture blueprint, grounded in the Federated Averaging literature and the FedECA methodology validated by Owkin (du Terrail et al., 2025) in Nature Communications.

Deploy the Architecture

We are actively seeking integration with Principal Investigators, academic hubs, and enterprise partners ready to operationalize this mathematical framework.

Contact the Core

Or reach us directly at contact@rzst.org